NASDAQ
According to Zyberno, ARCBEST CORPORATION (ARCB) is not a buy — WEAK BUSINESS (37/100) with a negative Margin of Safety of -100.0% and a Brina Gap of -25.7% showing the market already prices in more growth than the fundamentals support.
According to Zyberno's DCF model, ARCBEST CORPORATION (ARCB) trades at $136.54 against an estimated intrinsic value per share of $34.01 — a -100.0% Margin of Safety based on Owner Earnings of $170.40M TTM, projected at -26.9% growth for 10 years with a 2.5% terminal growth rate. The Brina Gap of -25.7% weakens the case: based on the company's ROIC (4.1%) and reinvestment rate (-101.3%), the business can fundamentally grow at -4.2% — but the current enterprise value implies the market expects 21.6%. This places ARCB in the Expensive Hype quadrant of the Brina Matrix, the most fragile combination — overvalued on cash AND overpriced on growth. Zyberno's model translates this into a 5-year expected return of -39.4% annually.
Over the trailing twelve months, ARCB generated $170.40M in Owner Earnings. Capital was deployed as follows: $7.42M returned via share buybacks, $10.79M paid as dividends, $110.01M invested in capital expenditures. Reinvestment rate: -101.3%. Owner Earnings have declined at 26.9% annually over the trailing five years using log-linear regression.